Nutraceuticals as anti-angiogenic agents: Hopes and reality

Journal of Physiology and Pharmacology

Volumn 56, Issue SUPPL. 1, 2005, Pages 51-67

  Dulak, Józef ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Angiogenesis; Atherosclerosis; Cancer; Polyphenols; Vascular endothelial growth factor

Indexed keywords

ACTEOSIDE; ANGIOGENESIS INHIBITOR; APIGENIN; BAICALEIN; BERBERINE; CATECHIN; CHEMOKINE; CURCUMIN; CYTOKINE; EPHRIN; EPICATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONE; GROWTH FACTOR; HORMONE; LUTEOLIN; NUTRACEUTICAL; POLYACETYLENE; POLYPHENOL; PROTEINASE; RESVERATROL; TRANSCRIPTION FACTOR; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ATHEROSCLEROSIS; CANCER; CONFERENCE PAPER; CURCUMA LONGA; DIET; FOOD INTAKE; GRAPE; HAIR GROWTH; HUMAN; NONHUMAN; OVULATION; PLANT SEED; RED WINE; TEA; TUMOR GROWTH; WOUND HEALING;

ANGIOGENESIS INHIBITORS; ANIMALS; ATHEROSCLEROSIS; CATECHIN; CURCUMIN; DIETARY SUPPLEMENTS; FLAVONOIDS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHENOLS; STILBENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33744723078     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (76)

1. Dulak J, Loboda A, Zagorska A et al. Complex role of heme oxygenase-1 in angiogenesis. Antioxid Redox Signal 2004; 6: 858-66.
2. Dulak J, Jozkowicz A. Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid Redox Signal 2003; 5: 123-32.
3. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-60.
4. Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-9.
5. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-42.
6. Huminiecki L, Chan HY, Lui S et al. Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection. Mol Hum Reprod 2001; 7: 255-64.
7. Dulak J, Jozkowicz A, Dichtl W et al. Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation. Atherosclerosis 2001; 159: 325-32.
8. Alber HF, Dulak J, Frick M et al. Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease. J Am Coll Cardiol 2002; 39: 1951-5.
9. Ramos MA, Kuzuya M, Esaki T et al. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1998; 18: 1188-96.
10. Inoue M, Itoh H, Tanaka T et al. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol 2001; 21: 560-6.
11. Inoue M, Itoh H, Ueda M et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98: 2108-16.
12. Cragg GM, Newman DJ. Medicinals for the millennia: the historical record. Ann N Y Acad Sci 2001; 953: 3-25.
13. Aggarwal BB, Bhardwaj A, Aggarwal RS et al. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004; 24: 2783-840.
14. Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer therapy. Cancer Lett 2004; 215: 129-40.
15. Cao Y, Cao R, Brakenhielm E. Antiangiogenic mechanisms of diet-derived polyphenols. J Nutr Biochem 2002; 13: 380-390.
16. Maulik N. Redox signaling of angiogenesis. Antioxid Redox Signal 2002; 4: 805-15.
17. Sen CK, Khanna S, Gordillo G et al. Oxygen, oxidants, and antioxidants in wound healing: an emerging paradigm. Ann N Y Acad Sci 2002; 957: 239-49.
18. Grzenkowicz-Wydra J, Cisowski J, Nakonieczna J et al. Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor. Mol Cell Biochem 2004; 264: 169-81.
19. Colavitti R, Pani G, Bedogni B et al. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 2002; 277: 3101-8.
20. Igura K, Ohta T, Kuroda Y et al. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 2001; 171: 11-6.
21. Lin MT, Yen ML, Lin CY et al. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol 2003; 64: 1029-36.
22. Brakenhielm E, Cao R, Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 2001; 15: 1798-800.
23. Oak MH, Chataigneau M, Keravis T et al. Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway. Arterioscler Thromb Vasc Biol 2003; 23: 1001-7.
24. Moulton KS, Vakili K, Zurakowski D et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003; 100: 4736-41.
25. Tseng SH, Lin SM, Chen JC et al. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 2004; 10: 2190-202.
26. Brown J, Reading SJ, Jones S et al. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 2000; 80: 37-45.
27. Kimura Y, Okuda H. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 2001; 131: 1844-9.
28. Kimura Y, Okuda H. Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice. J Pharm Pharmacol 2000; 52: 1287-95.
29. Khanna S, Venojarvi M, Roy S et al. Dermal wound healing properties of redox-active grape seed proanthocyanidins. Free Radic Biol Med 2002; 33: 1089-96.
30. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23: 363-98.
31. Witek-Zawada B, Koj A. Regulation of expression of stromyelysin-1 by proinflammatory cytokines in mouse brain astrocytes. J Physiol Pharmacol 2003; 54: 489-96.
32. Arbiser JL, Klauber N, Rohan R et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998; 4: 376-83.
33. Bobrovnikova-Marjon EV, Marjon PL, Barbash O et al. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. Cancer Res 2004; 64: 4858-69.
34. Okamoto T, Yamagishi S, Inagaki Y et al. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB J 2002; 16: 1928-30.
35. Shim JS, Kim JH, Cho HY et al. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin. Chem Biol 2003; 10: 695-704.
36. Kim JH, Shim JS, Lee SK et al. Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase. Jpn J Cancer Res 2002; 93: 1378-85.
37. Leyon PV, Kuttan G. Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis. J Exp Clin Cancer Res 2003; 22: 77-83.
38. Gururaj AE, Belakavadi M, Venkatesh DA et al. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 2002; 297: 934-42.
39. Cheng AL, Hsu CH, Lin JK et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001; 21: 2895-900.
40. Garcea G, Jones DJ, Singh R et al. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 2004; 90: 1011-5.
41. Sharma RA, Euden SA, Platton SL et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004; 10: 6847-54.
42. Jung YD, Ellis LM. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int J Exp Pathol 2001; 82: 309-16.
43. Kojima-Yuasa A, Hua JJ, Kennedy DO et al. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Life Sci 2003; 73: 1299-313.
44. Tang FY, Nguyen N, Meydani M. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer 2003; 106: 871-8.
45. Lai HC, Chao WT, Chen YT et al. Effect of EGCG, a major component of green tea, on the expression of Ets-1, c-Fos, and c-Jun during angiogenesis in vitro. Cancer Lett 2004; 213: 181-8.
46. Park AM, Dong Z. Signal transduction pathways: targets for green and black tea polyphenols. J Biochem Mol Biol 2003; 36: 66-77.
47. Yamakawa S, Asai T, Uchida T et al. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Lett 2004; 210: 47-55.
48. Fassina G, Vene R, Morini M et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res 2004; 10: 4865-73.
49. Oku N, Matsukawa M, Yamakawa S et al. Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP. Biol Pharm Bull 2003; 26: 1235-8.
50. Sartippour MR, Heber D, Henning S et al. cDNA microarray analysis of endothelial cells in response to green tea reveals a suppressive phenotype. Int J Oncol 2004; 25: 193-202.
51. Sartippour MR, Heber D, Zhang L et al. Inhibition of fibroblast growth factors by green tea. Int J Oncol 2002; 21: 487-91.
52. Trompezinski S, Denis A, Schmitt D et al. Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the proinflammatory cytokine TNFalpha. Arch Dermatol Res 2003; 295: 112-6.
53. Jung YD, Kim MS, Shin BA et al. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 2001; 84: 844-50.
54. Jatoi A, Ellison N, Burch PA et al. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003; 97: 1442-6.
55. Greenwald P. Clinical trials in cancer prevention: current results and perspectives for the future. J Nutr 2004; 134: 3507S-3512S.
56. Sengupta S, Toh SA, Sellers LA et al. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 2004; 110: 1219-25.
57. Foster BC, Arnason JT, Briggs CJ. Natural Health Products and Drug Disposition. Annu Rev Pharmacol Toxicol 2004.
58. Morbidelli L, Chang CH, Douglas JG et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996; 270: H411-5.
59. Dulak J, Jozkowicz A. Nitric oxide and angiogenic activity of endothelial cells: direct or VEGF-dependent effect? Cardiovasc Res 2002; 56: 487-8; author reply 489-91.
60. Jozkowicz A, Dulak J, Nigisch A et al. Involvement of nitric oxide in angiogenic activities of vascular endothelial growth factor isoforms. Growth Factors 2004; 22: 19-28.
61. Morisaki N, Watanabe S, Tezuka M et al. Mechanism of angiogenic effects of saponin from ginseng Radix rubra in human umbilical vein endothelial cells. Br J Pharmacol 1995; 115: 1188-93.
62. Sato K, Mochizuki M, Saiki I et al. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull 1994; 17: 635-9.
63. Kong W, Wei J, Abidi P et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004; 10: 1344-51.
64. Jayaraman KS. Technology, tradition unite in India's drug discovery scheme. Nat Med 2003; 9: 982.
65. Normile D. Asian medicine. The new face of traditional Chinese medicine. Science 2003; 299: 188-90.
66. Arakaki N, Toyofuku A, Emoto Y et al. Induction of G1 cell cycle arrest in human umbilical vein endothelial cells by flavone's inhibition of the extracellular signal regulated kinase cascade. Biochem Cell Biol 2004; 82: 583-8.
67. Bagli E, Stefaniotou M, Morbidelli L et al. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity. Cancer Res 2004; 64: 7936-46.
68. Radzikowski C, Wietrzyk J, Grynkiewicz G et al. [Genistein: a soy isoflavone revealing a pleiotropic mechanism of action - clinical implications in the treatment and prevention of cancer]. Postepy Hig Med Dosw (Online) 2004; 58: 128-39.
69. Ravindranath MH, Muthugounder S, Presser N et al. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 2004; 546: 121-65.
70. Osada M, Imaoka S, Funae Y. Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein. FEBS Lett 2004; 575: 59-63.
71. Sartippour MR, Seeram NP, Heber D et al. Rabdosia rubescens inhibits breast cancer growth and angiogenesis. Int J Oncol 2005; 26: 121-7.
72. Ho JC, Konerding MA, Gaumann A et al. Fungal polysaccharopeptide inhibits tumor angiogenesis and tumor growth in mice. Life Sci 2004; 75: 1343-56.
73. Wu LW, Chiang YM, Chuang HC et al. Polyacetylenes function as anti-angiogenic agents. Pharm Res 2004; 21: 2112-9.
74. Roy S, Khanna S, Alessio HM et al. Anti-angiogenic property of edible berries. Free Radic Res 2002; 36: 1023-31.
75. Wartenberg M, Budde P, De Marees M et al. Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional chinese medicine. Lab Invest 2003; 83: 87-98.
76. Wang S, Zheng Z, Weng Y et al. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci 2004; 74: 2467-78.